AI Issuer Brief
Arphra AILoading cached brief…
Peers
No peer list available for PLSE.
Price change · trailing returns
Live · FMP| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.05% | -3.44% | +18.09% | +33.48% | +82.62% | +82.08% | +48.10% | +303.23% | +33.26% | +482.75% | +499.52% |
Aftermarket
Live · FMPLast trade
$24.85
84 sh
Bid
$24.55
200 sh
Ask
$26.50
75 sh
Spread
$1.950
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $30.00 (+20.00%)
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- ATM Equity Purchases by Pulse Biosciences' Co-Chairmen Total Approximately $13.3 Millionbusinesswire.com·May 12, 2026
- ATM Equity Purchases by Pulse Biosciences' Co-Chairmen Total Approximately $13.3 Millionbusinesswire.com·May 12, 2026
- Pulse Biosciences Q1 Earnings Call Highlightsmarketbeat.com·May 08, 2026
- Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conferencebusinesswire.com·May 08, 2026
- Pulse Biosciences, Inc. (PLSE) Q1 2026 Earnings Call Transcriptseekingalpha.com·May 08, 2026
- Pulse Biosciences, Inc (PLSE) Reports Q1 Loss, Lags Revenue Estimateszacks.com·May 04, 2026
- Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Resultsbusinesswire.com·May 04, 2026
- Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Resultsbusinesswire.com·May 04, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
DUGGAN ROBERT W director, 10 percent owner: | Buy | 660,233 | $13M | May 11, 2026 |
LAVIOLETTE PAUL A director, officer: Chief Executive Officer | Buy | 15,000 | $295.35K | May 11, 2026 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|